Heart Failure News and Research

RSS
Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.
Hestia criteria, sPESI score can be used to select pulmonary embolism patients for outpatient care

Hestia criteria, sPESI score can be used to select pulmonary embolism patients for outpatient care

Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction

Empagliflozin reduces risk of death in patients with heart failure and reduced ejection fraction

Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy

Patients with newly diagnosed atrial fibrillation benefit from early rhythm control therapy

Study: Mavacamten improves heart function in patients with hypertrophic cardiomyopathy

Study: Mavacamten improves heart function in patients with hypertrophic cardiomyopathy

DAPA-CKD trial shows dapagliflozin reduces risk of chronic kidney disease

DAPA-CKD trial shows dapagliflozin reduces risk of chronic kidney disease

Researchers identify roles of matrix stiffness and mechanotransduction in cardiac reprogramming

Researchers identify roles of matrix stiffness and mechanotransduction in cardiac reprogramming

High blood pressure can be treated without causing erectile dysfunction, shows study

High blood pressure can be treated without causing erectile dysfunction, shows study

Influenza, pneumonia vaccinations associated with fewer deaths in heart failure patients

Influenza, pneumonia vaccinations associated with fewer deaths in heart failure patients

MedAxiom release its eighth annual cardiovascular provider compensation and production survey

MedAxiom release its eighth annual cardiovascular provider compensation and production survey

Gout drug may improve heart function in individuals with congenital heart disease

Gout drug may improve heart function in individuals with congenital heart disease

AstraZeneca partners with World Heart Federation to reduce the global burden of heart failure

AstraZeneca partners with World Heart Federation to reduce the global burden of heart failure

Anticoagulation therapy associated with improved survival among COVID-19 patients

Anticoagulation therapy associated with improved survival among COVID-19 patients

Cognitive impairment linked to increased risk of rehospitalization in heart failure patients

Cognitive impairment linked to increased risk of rehospitalization in heart failure patients

AHA statement provides steps for reducing stroke risk in patients undergoing heart surgery

AHA statement provides steps for reducing stroke risk in patients undergoing heart surgery

Hispanic or Latinx adults exposed to pollution at work more likely to have heart abnormalities

Hispanic or Latinx adults exposed to pollution at work more likely to have heart abnormalities

Study: Hydroxychloroquine plus azithromycin linked to significant cardiovascular risks

Study: Hydroxychloroquine plus azithromycin linked to significant cardiovascular risks

A person's socioeconomic status can help predict heart failure mortality

A person's socioeconomic status can help predict heart failure mortality

Heart Research UK awards over £145,000 to Queen’s University Belfast project on blood vessel grafts

Heart Research UK awards over £145,000 to Queen’s University Belfast project on blood vessel grafts

RNA-targeting compound restarts a healing factor silenced by heart attack

RNA-targeting compound restarts a healing factor silenced by heart attack

Strand-like muscle fibers in the heart tied to heart failure risk

Strand-like muscle fibers in the heart tied to heart failure risk

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.